Newmont stock lifts as gold rebounds hard; investors eye Feb. 19 results call

Newmont stock lifts as gold rebounds hard; investors eye Feb. 19 results call

New York, Feb 3, 2026, 14:08 EST — Regular session

  • Newmont shares climbed roughly 2.6% in afternoon trading, bouncing back after nearly a $5 swing during the session
  • After plunging over two sessions, gold bounced back sharply, climbing nearly 7% and lifting miners along with related ETFs.
  • Traders eye bullion swings as Newmont prepares to release its Feb. 19 results, seeking insights on costs and future outlook

Newmont shares climbed Tuesday, hitting a session peak of $119.58 before settling up 2.6% at $115.73 in New York.

Precious metals staged a sharp bounce after getting hammered over the past two sessions. By late morning, spot gold had surged 6.9% to $4,985.44 an ounce, with silver soaring 11.7%, Reuters calculations showed. Peter Grant from Zaner Metals described the recent dip as a “corrective” move within a broader uptrend, pointing to $4,400 as key support and $5,100 as resistance. Reuters

Why it matters now: gold has become a barometer for macro stress, with miners often intensifying the metal’s moves since their cash flow tracks bullion prices. On Monday, selling pressure was fueled further by increased margin requirements from CME Group — the cash traders must post to hold futures bets — just as Kevin Warsh was named to lead the Federal Reserve when Jerome Powell steps down in May. John Meyer at SP Angel described the scene as a “rollercoaster ride,” while Michael Hsueh at Deutsche Bank warned that the backdrop doesn’t suggest a sustained gold price rebound. Reuters

Flows data highlight just how crowded the trade has become. ETFs linked to gold and other precious metals raked in $4.39 billion in January, with gold miner ETFs pulling $3.62 billion—the largest monthly inflow since at least 2009, according to LSEG Lipper. Investors funneled $539 million into the VanEck Gold Miners ETF, while SPDR Gold Shares hauled in $2.58 billion, the data showed. J.P. Morgan remains “firmly bullishly convicted” on gold over the medium term, a note said. Reuters

The bank’s latest projection quantifies the bullish outlook: gold is set to hit $6,300 an ounce by the end of 2026, with central banks expected to buy 800 tons this year. Deutsche Bank stuck to its $6,000 target for 2026, Reuters reported.

The gold-miner sector strengthened alongside bullion. The VanEck Gold Miners ETF climbed roughly 2.3%. Agnico Eagle and Kinross rose around 1.1% and 2.9%, respectively.

But the situation works both ways. If bullion reverses today’s gains—or if margin calls push leveraged traders to sell off—miners could tumble sharply, even without any fresh negative company news. A firmer dollar or a change in rate-cut expectations would also drain support from non-yielding gold.

Investors in Newmont are focusing beyond just the metal itself — they want to see solid production and cost trajectories, plus reassurance that management will maintain capital returns amid price swings. While miners can’t influence gold prices, strong execution still proves crucial, especially when volatility squeezes margins.

Newmont is gearing up for its next major event: the fourth-quarter and full-year 2025 results call scheduled for Feb. 19 at 5:30 p.m. ET.

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap

NYSE: AER 95 / 100
#2 BUY

Constellation Energy

NASDAQ: CEG 94 / 100
#3 BUY ON PULLBACK

Cheniere Energy

NYSE: LNG 92 / 100
#4 BUY

Walt Disney

NYSE: DIS 90 / 100
#5 ACCUMULATE

AIG

NYSE: AIG 88 / 100
View full portfolio
Editorial model selection. Not personalised advice.
Boston Scientific stock slips today: what to know before earnings and key Watchman trial data
Previous Story

Boston Scientific stock slips today: what to know before earnings and key Watchman trial data

Pfizer stock drops after obesity-drug data, even as 2026 outlook holds
Next Story

Pfizer stock drops after obesity-drug data, even as 2026 outlook holds